Soc. Generale Knock-Out MRK 21.06.../ DE000SU630J0 /
21/05/2024 18:08:10 | Chg.-0.220 | Bid18:26:31 | Ask18:26:31 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
4.020EUR | -5.19% | 4.010 Bid Size: 1,000 |
4.410 Ask Size: 1,000 |
MERCK KGAA O.N. | - EUR | 21/06/2024 | Call |
GlobeNewswire
07/05
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire
06/05
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire
04/03
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
21/12/2023
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
14/12/2023
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
17/10/2023
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA